{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:11:36Z","timestamp":1787235096575,"version":"build-2736575974"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2020.00605","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T10:47:24Z","timestamp":1593773244000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy"],"prefix":"10.3389","volume":"11","author":[{"given":"Chiara","family":"Passarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Selvatici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Di Raimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sofia","family":"Falzarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Bushby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Reza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Zharaieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Merlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Sabatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Borgiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Pane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Claustres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Tuffery-Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Aartsma-Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Spitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A. C.","family":"T\u2019Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Al-Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Kotelnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lebowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Scapoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ferlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"918","DOI":"10.15252\/emmm.201303724","article-title":"Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies.","volume":"6","author":"Ayoglu","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.ajhg.2016.08.023","article-title":"Association study of exon variants in the NF-\u03baB and TGF\u03b2 pathways identifies CD40 as a modifier of duchenne muscular dystrophy.","volume":"99","author":"Bello","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ana.24370","article-title":"Genetic modifiers of ambulation in the cooperative international neuromuscular research group Duchenne natural history study.","volume":"77","author":"Bello","year":"2015","journal-title":"Ann. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/jnnp.2005.078345","article-title":"The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy.","volume":"77","author":"Bonifati","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/humu.22017","article-title":"Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array.","volume":"33","author":"Bovolenta","year":"2012","journal-title":"Hum. Mutat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"DMD care considerations working group. diagnosis and management of duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/em.21797","article-title":"Deciphering the complex: methodological overview of statistical models to derive OMICS-based biomarkers.","volume":"54","author":"Chadeau-Hyam","year":"2013","journal-title":"Environ. Mol. Mutagen."},{"key":"B8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00432-012-1332-x","article-title":"Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb.","volume":"139","author":"Chao","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1177\/1535370215579167","article-title":"Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.","volume":"240","author":"Dai","year":"2015","journal-title":"Exp. Biol. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/ijc.20008","article-title":"Mutation analysis of the apoptotic \u201cdeath-receptors\u201d and the adaptors TRADD and FADD\/MORT-1 in osteosarcoma tumor samples and osteosarcoma cell lines.","volume":"109","author":"Dechant","year":"2004","journal-title":"Int. J. Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.nmd.2014.09.004","article-title":"204th ENMC international workshop on biomarkers in duchenne muscular dystrophy 24-26 January 2014, Naarden, The Netherlands.","volume":"25","author":"Ferlini","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1096\/fj.04-2511fje","article-title":"Prednisolone-induced changes in dystrophic skeletal muscle.","volume":"19","author":"Fisher","year":"2005","journal-title":"FASEB J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.23819","article-title":"LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.","volume":"73","author":"Flanigan","year":"2013","journal-title":"Ann. Neurol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-014-0287","article-title":"Current treatment and management of dystrophinopathies.","volume":"16","author":"Goemans","year":"2014","journal-title":"Curr. Treat. Options Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1212\/WNL.0000000000003217","article-title":"Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.","volume":"87","author":"Griggs","year":"2016","journal-title":"Neurology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1096\/fj.08-111005","article-title":"Life and death by death receptors.","volume":"23","author":"Guicciardi","year":"2009","journal-title":"FASEB J."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-016-9109-x","article-title":"Clinical utility of serum biomarkers in Duchenne muscular dystrophy.","volume":"13","author":"Hathout","year":"2016","journal-title":"Clin. Proteomics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/emmm.201302621","article-title":"VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects.","volume":"5","author":"Heier","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14143","article-title":"Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy.","volume":"8","author":"Hogarth","year":"2017","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010053","article-title":"Dystrophin deficiency leads to genomic instability in human pluripotent stem cells via NO synthase-induced oxidative stress.","volume":"8","author":"Jelinkova","year":"2019","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1093\/bioinformatics\/btr521","article-title":"adegenet 1.3-1: new tools for the analysis of genome-wide SNP data.","volume":"27","author":"Jombart","year":"2011","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2156-11-94","article-title":"Discriminant analysis of principal components: a new method for the analysis of genetically structured populations.","volume":"11","author":"Jombart","year":"2010","journal-title":"BMC Genet."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002365","article-title":"Novel approach to meta-analysis of microarray datasets reveals muscle remodeling-related drug targets and biomarkers in Duchenne muscular dystrophy.","volume":"8","author":"Kotelnikova","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.jaci.2018.09.034","article-title":"Integrative approach identifies corticosteroid response variant in diverse populations with asthma.","volume":"143","author":"Levin","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"B25","first-page":"141","article-title":"The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review.","volume":"31","author":"Magnotti","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","article-title":"Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"390","author":"McDonald","year":"2017","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"CINRG investigators. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.","volume":"391","author":"McDonald","year":"2018","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/mus.10319","article-title":"Early prednisone treatment in Duchenne muscular dystrophy.","volume":"27","author":"Merlini","year":"2003","journal-title":"Muscle Nerve"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mce.2013.03.002","article-title":"Complex genomic interactions in the dynamic regulation of transcription by the glucocorticoid receptor.","volume":"380","author":"Miranda","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.2217\/epi-2016-0088","article-title":"Noncoding RNAs and Duchenne muscular dystrophy.","volume":"8","author":"Perry","year":"2016","journal-title":"Epigenomics"},{"key":"B31","year":"2011","journal-title":"R: A Language for Statistical Computing."},{"key":"B32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/jnnp-2014-309405","article-title":"The NorthStar ambulatory assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.","volume":"87","author":"Ricotti","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1158\/1078-0432.CCR-05-0182","article-title":"Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.","volume":"11","author":"Runnebaum","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S2352-4642(18)30140-8","article-title":"Genetic therapies for inherited neuromuscular disorders.","volume":"2","author":"Scoto","year":"2018","journal-title":"Lancet Child Adolesc. Health"},{"key":"B35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.yexcr.2013.12.020","article-title":"Biomarkers in rare neuromuscular diseases.","volume":"325","author":"Scotton","year":"2014","journal-title":"Exp. Cell. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.ymthe.2018.07.021","article-title":"Membrane stabilization by modified steroid offers a potential therapy for muscular dystrophy due to dysferlin deficit.","volume":"26","author":"Sreetama","year":"2018","journal-title":"Mol. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DNND.S121099","article-title":"Biomarkers of Duchenne muscular dystrophy: current findings.","volume":"8","author":"Szigyarto","year":"2018","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/hmg\/ddh149","article-title":"Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.","volume":"13","author":"Tantisira","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJMoa0911353","article-title":"Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma.","volume":"365","author":"Tantisira","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome.","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cytogfr.2010.04.003","article-title":"Crosstalk between TNF and glucocorticoid receptor signaling pathways.","volume":"21","author":"Van Bogaert","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/jnnp-2014-308409","article-title":"Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants.","volume":"86","author":"van den Bergen","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/WCO.0000000000000240","article-title":"Modifier genes and their effect on Duchenne muscular dystrophy.","volume":"28","author":"Vo","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/ng.2974","article-title":"Dystrophin is a tumor suppressor in human cancers with myogenic programs.","volume":"46","author":"Wang","year":"2014","journal-title":"Nat. Genet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/nm.3628","article-title":"Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice.","volume":"20","author":"Wein","year":"2014","journal-title":"Nat. Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/ana.25283","article-title":"Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy.","volume":"84","author":"Weiss","year":"2018","journal-title":"Ann Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1210\/en.2017-00728","article-title":"Glucocorticoid signaling in health and disease: insights from tissue-specific GR knockout mice.","volume":"159","author":"Whirledge","year":"2018","journal-title":"Endocrinology"},{"key":"B48","first-page":"2747","article-title":"Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma.","volume":"59","author":"Zhang","year":"1999","journal-title":"Cancer Res."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2020.00605\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T10:47:29Z","timestamp":1593773249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2020.00605\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":48,"alternative-id":["10.3389\/fgene.2020.00605"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2020.00605","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"article-number":"605"}}